PROSPECT OF PHARMACEUTICAL INDUSTRY IN BANGLADESH OFFER AFTER 2018

1. PROSPECT OF PHARMACEUTICAL
INDUSTRY IN BANGLADESH OFFER
AFTER 2018
Presented By: Department of Pharmacy
13th Batch DIU

2. INTRODUCTION
 The pharmaceutical industry is one of the most technologically
advanced sectors currently in existence in Bangladesh. It has grown
in the last two decades at a considerable rate. The skills and
knowledge of the professionals and innovative ideas of the people
involved in this industry are the key factors for these developments.
 About 300 pharmaceutical companies are operating at the moment.
Only 3% of the drugs are imported, the remaining 97% come from
local companies. Positive developments in the pharmaceutical sector
have enabled Bangladesh to export medicine to global markets. By
overcoming the underlying obstacles this sector can develop more
and can be an effective exporting sector of Bangladesh.

3.  With a current market size of $1.2 billion, the market is poised to cross $2
billion by 2018. In fact, provided the political situation remains as stable as it
has been for the last year, the growth may be even higher than projected.

4. THE BALANCING ACT BETWEEN GLOBAL AND DOMESTIC MARKETS:
According to IMS projections, the global pharmaceutical market will grow to USD
1.135 trillion from USD 953 billion at a compound annual growth rate (CAGR) of 3-6%
during 2013-2017.The local market size currently rests at USD 1.53 billion, with local
manufacturers meeting 97% of the demand.

5. PROSPECT OF PHARMACEUTICAL INDUSTRY IN BANGLADESH OFFER
IN/AFTER 2018
I. Prospects of Marketing
II. Prospects of Foreign competition
III. Prospects of Export
IV. Prospects of Customer Choices
V. Prospects of Power Development

6. ACCORDING TO BDMEDICINES.COM PROSPECT OF
PHARMACEUTICAL INDUSTRY IN BANGLADESH OFFER IN 2018:
 As people are getting educated, they are now more conscious about
healthcare. In this regard, the demand of “wellness” drugs, vaccines, medical
devices, etc. is increasing day by day. So there is a positive sign for
pharmaceuticals manufacturer.
 Two top most companies have already received the approval of FDA (Food
and Drug Administration, USA), and one of them start to export their
products in USA. Which is a milestone for Bangladesh pharmaceutical sector
and this achievement will widen the future of this sector.
 Aiming at minimizing the import dependency on basic drugs, the country's
prime concern is about building up of own capability in the manufacturing of
active pharmaceutical ingredients(APIs), base materials and other allied
industry inputs. Some of the top listed companies already start to
manufacture API in local environment.

7.  Due to increase the demands for different technology based medical products few
companies have started to produce medical devices also. This will be another very
promising branch of pharmaceutical industries within few years.
So it's clear that, the current position of the pharmaceutical industries in Bangladesh is
giving a signal of bright and strong platform in global Pharma market in future.

8. PROSPECT OF PHARMACEUTICAL BIOTECHNOLOGY IN BANGLADESH (2018)
 Bangladesh has tremendous possibilities to do a lot better by focusing on
biotechnology and genetic engineering.
 A very exciting field of biotechnology is bioinformatics which is actually the
marriage between biology and computer science, where enormous amount of
data that are being produced in the biological research laboratories around the
globe are compared, analyzed, and annotated to discover new genes,
characterize them, develop new drugs and build complex biological
networks.
 The pharmaceutical companies of Bangladesh are also turning to the biotech
products. Some companies have already introduced some biotech products
like human insulin, anticancer drugs, etc. and some are on the process of
launching many other biotech products.

9. BIOTECH PRODUCTS FOR THE MANAGEMENT OF DISEASES
● Drug for Autoimmune diseases and Inflammation
● Blood and Lymphatic System products
● Anti-cancers drugs
● Hormones & Enzymes
● Cardiovascular drugs
● Drugs act on CNS disorders (e.g., Alzheimer's disease, stroke, Parkinson’s disease,
schizophrenia)
● Drugs act on digestive system (e.g., liver diseases)
● Antibiotics and anti-infective drugs (e.g., hepatitis B & C)
● Drugs for kidneys and Genito-Urinary system disorders (e.g. urogenital diseases,
renal failure)
● Drugs for metabolic disorders (e.g. diabetes, obesity)

10. EXPORT OPPORTUNITIES
 Government has set target to earn $5 billion from the pharmaceuticals by 2021. In
attaining the target exploring new markets is very crucial for the sector.
 According to the Export Promotion Bureau (EPB) data, Bangladesh earned $89
million from exporting pharmaceutical goods in the last fiscal year, which was $82.11
million in FY2015-16.
 The government should provide gas connections to the API Park as soon as possible
to help pharma companies start production there, he added.
 “Patent waiver has made people interested to invest in the pharma sector. It will
increase the production capacity, which will push the export earnings up in near
future,” said Shafiuzzaman.

12. HOW TO MAKE 2018 A SUCCESSFUL YEAR FOR
PHARMACEUTICALS
 Prime Minister Sheikh Hasina on Monday January 02, 2018 declared the
pharmaceuticals products as the ‘product of the year’ to help boosting the export to
grab more global market share.
 She declared the pharmaceuticals as the ‘product of the year’, saying the
government would provide support to the sector to boost the export of medicines
and other pharmaceutical products abroad during the year, reports BSS.
 “It is not only a positive decision but also a timely decision. On behalf of the
pharmaceuticals manufacturers, I welcome the prime minister’s decision to consider
the sector as product of the year,” Bangladesh Association of Pharmaceutical
Industries (Bapi) Advisor Abdul Muktadir told the Dhaka Tribune.

14. EXPERT RECOMMENDATION
I. Providing sufficient gas and electricity according to the demand.
II. Political stability is very much needed. Due to strike & other political unrests the marketing
process is being interrupted & the distribution channel lose their natural speed.
III. 80% of the raw materials of this industry are imported from foreign countries. If the raw
materials can be produced sufficiently in the domestic level, the pharmaceutical companies
will be able to supply according to the demand.
IV. Upgrading the regulatory body to WHO standard. It will let Bangladesh enter into the global
market and thus will increase the production a great deal.
V. Like India & other competitor countries, bank loan interest rates should be reduced for this
industry.